Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy

Background: Left ventricular hypertrophy (LVH) is a frequent echocardiographic feature in Fabry disease (FD) and in severe cases may be confused with hypertrophic cardiomyopathy (HCM) of other origin. The prevalence of FD in patients primarily diagnosed with HCM varies considerably in screening and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaggl, Martina, Lajic, Natalija, Heinze, Georg, Voigtländer, Till, Sunder-Plassmann, Raute, Paschke, Eduard, Fauler, Günter, Sunder-Plassmann, Gere, Mundigler, Gerald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879766/
https://www.ncbi.nlm.nih.gov/pubmed/27226774
http://dx.doi.org/10.7150/ijms.14997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879766/
https://www.ncbi.nlm.nih.gov/pubmed/27226774
http://dx.doi.org/10.7150/ijms.14997

Ejemplares similares